ATTO — Attovia Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 2058707 ·
Last close
$17.14
Market Cap
—
52W High
$28.00
52W Low
$16.15
ADV30
346,586
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 450,000 | — | -21,803,000 | -20,687,000 | 128,348,000 | 32,829,000 | 273,807,000 |
| Mar 2026 | 0 | — | -19,955,000 | -18,656,000 | 146,086,000 | 43,297,000 | 271,601,000 |
| Jun 2025 | 0 | — | -16,620,000 | -14,439,000 | — | — | — |
| Mar 2025 | 0 | — | -16,104,000 | -15,151,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-32,272,000
Investing CF
$-6,808,000
Financing CF
$140,653,000
CapEx
$-2,080,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.33
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-129,666,000
Inventory
—
Receivables
$700,000
ST Investments
$89,325,000
EBIT TTM
$-36,059,000
Pretax Income TTM
$-33,807,000
Interest Exp TTM
—
Analysts
5
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,350,000 | -67,159,000 | -60,627,000 | 165,893,000 | 273,329,000 | -107,436,000 | -59,199,000 |
| Dec 2024 | 0 | -41,553,000 | -39,801,000 | 76,716,000 | 123,541,000 | -46,825,000 | -35,035,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $227.88B | $421.51 | — |
| GILD | GILEAD SCIENCES, INC. | $184.82B | $149.05 | — |
| MRNA | Moderna, Inc. | $76.88B | $192.57 | — |
| ARGX | ARGENX SE | $59.63B | $958.91 | — |
| RVMD | Revolution Medicines, Inc. | $43.99B | $205.26 | — |
News headlines (Yahoo Finance, 1h cache)
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
2026-09-28 20:05 · Yahoo
Attovia Therapeutics (ATTO) Pulls Back As Investors Ask If The Valuation Still Fits
2026-09-22 03:25 · Yahoo
Attovia Therapeutics to Participate in Upcoming Investor Conferences
2026-09-03 20:05 · Yahoo
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
2026-09-02 20:05 · Yahoo
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
2026-08-31 15:16 · Yahoo
Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
2026-09-22 17:39 · Yahoo
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
2026-08-31 13:45 · Yahoo
Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More
2026-08-31 11:56 · Yahoo
Moderna Stock Carries A Market Value Its Revenue Does Not Support
2026-08-26 15:13 · Yahoo
Moderna Stock Had A Readout Waiting In Plain Sight
2026-08-24 19:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.